873 related articles for article (PubMed ID: 26768987)
41. Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation.
Meyer RG; Britten CM; Wehler D; Bender K; Hess G; Konur A; Hartwig UF; Wehler TC; Ullmann AJ; Gentilini C; Uharek L; Huber C; Kolbe K; Herr W
Blood; 2007 Jan; 109(1):374-82. PubMed ID: 16940425
[TBL] [Abstract][Full Text] [Related]
42. Early recovery of natural killer cells post T-cell depleted allogeneic stem cell transplantation using alemtuzumab "in the bag".
Davison GM; Opie JJ; Davids SFG; Mohammed R; Novitzky N
Transpl Immunol; 2024 Jun; 84():102045. PubMed ID: 38641148
[TBL] [Abstract][Full Text] [Related]
43. Automatic generation of alloreactivity-reduced donor lymphocytes and hematopoietic stem cells from the same mobilized apheresis product.
Wiercinska E; Quade-Lyssy P; Hümmer C; Beifuß J; Akarkach K; Poppe C; Olevska V; Dzionek J; Lahnor H; Bosio A; Papanikolaou E; Bonig H
J Transl Med; 2023 Nov; 21(1):849. PubMed ID: 38007485
[TBL] [Abstract][Full Text] [Related]
44. Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia.
Isgrò A; Marziali M; Sodani P; Gaziev J; Erer B; Polchi P; Paciaroni K; Roveda A; De Angelis G; Gallucci C; Alfieri C; Simone MD; Zinno F; Isacchi G; Adorno G; Lanti A; Leti W; Aiuti F; Fraboni D; Andreani M; Lucarelli G
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1557-66. PubMed ID: 20546907
[TBL] [Abstract][Full Text] [Related]
45. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience.
Knutsen AP; Wall DA
J Clin Immunol; 2000 Nov; 20(6):466-76. PubMed ID: 11202237
[TBL] [Abstract][Full Text] [Related]
46. Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation.
Passweg JR; Tichelli A; Meyer-Monard S; Heim D; Stern M; Kühne T; Favre G; Gratwohl A
Leukemia; 2004 Nov; 18(11):1835-8. PubMed ID: 15457184
[TBL] [Abstract][Full Text] [Related]
47. Haploidentical peripheral blood stem cell transplantation with a combination of CD34 selection and T cell depletion as graft-versus-host disease prophylaxis in a patient with severe combined immunodeficiency.
Martín-Hernández MP; Arrieta R; Martínez A; García P; Jimenez-Yuste V; Hernandez-Navarro F
Bone Marrow Transplant; 1997 Nov; 20(9):797-9. PubMed ID: 9384486
[TBL] [Abstract][Full Text] [Related]
48. Unmanipulated donor lymphocytes for EBV-related PTLD after T-cell depleted HLA-haploidentical transplantation.
De Pasquale MD; Mastronuzzi A; De Vito R; Cometa A; Inserra A; Russo C; De Ioris MA; Locatelli F
Pediatrics; 2012 Jan; 129(1):e189-94. PubMed ID: 22144701
[TBL] [Abstract][Full Text] [Related]
49. Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors.
Yan CH; Wang JZ; Liu DH; Xu LP; Chen H; Liu KY; Huang XJ
Eur J Haematol; 2013 Oct; 91(4):304-14. PubMed ID: 23837640
[TBL] [Abstract][Full Text] [Related]
50. T-cell receptor αβ
Shah RM; Elfeky R; Nademi Z; Qasim W; Amrolia P; Chiesa R; Rao K; Lucchini G; Silva JMF; Worth A; Barge D; Ryan D; Conn J; Cant AJ; Skinner R; Abd Hamid IJ; Flood T; Abinun M; Hambleton S; Gennery AR; Veys P; Slatter M
J Allergy Clin Immunol; 2018 Apr; 141(4):1417-1426.e1. PubMed ID: 28780238
[TBL] [Abstract][Full Text] [Related]
51. Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk.
Hsieh MH; Varadi G; Flomenberg N; Korngold R
Biol Blood Marrow Transplant; 2002; 8(6):303-15. PubMed ID: 12108916
[TBL] [Abstract][Full Text] [Related]
52. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity.
Bethge WA; Haegele M; Faul C; Lang P; Schumm M; Bornhauser M; Handgretinger R; Kanz L
Exp Hematol; 2006 Dec; 34(12):1746-52. PubMed ID: 17157172
[TBL] [Abstract][Full Text] [Related]
53. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F
Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
[TBL] [Abstract][Full Text] [Related]
54. Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cells.
Müller N; Landwehr K; Langeveld K; Stenzel J; Pouwels W; van der Hoorn MAWG; Seifried E; Bonig H
Cytotherapy; 2018 Apr; 20(4):532-542. PubMed ID: 29500069
[TBL] [Abstract][Full Text] [Related]
55. Immunosuppression for 6-8 weeks after modified donor lymphocyte infusion reduced acute graft-versus-host disease without influencing graft-versus-leukemia effect in haploidentical transplant.
Yan C; Xu L; Liu D; Chen H; Wang Y; Liu K; Huang X
Chin Med J (Engl); 2014; 127(20):3602-9. PubMed ID: 25316237
[TBL] [Abstract][Full Text] [Related]
56. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
[TBL] [Abstract][Full Text] [Related]
57. Successful haploidentical hematopoietic stem cell transplantation in a patient with SCID due to CD3ε deficiency: need for IgG-substitution 6 years later.
Fuehrer M; Pannicke U; Schuetz C; Jacobsen EM; Schulz A; Friedrich W; Schwarz K; Hönig M
Klin Padiatr; 2014 May; 226(3):149-53. PubMed ID: 24515816
[TBL] [Abstract][Full Text] [Related]
58. Co-transplantation of mesenchymal stromal cell and haploidentical hematopoietic stem cell with TCR αβ depletion in children with primary immunodeficiency syndromes.
Atay D; Akcay A; Akinci B; Yenigurbuz FD; Ovali E; Ozturk G
Pediatr Transplant; 2021 Dec; 25(8):e14120. PubMed ID: 34409718
[TBL] [Abstract][Full Text] [Related]
59. Selective T-cell depletion targeting CD45RA as a novel approach for HLA-mismatched hematopoietic stem cell transplantation in pediatric nonmalignant hematological diseases.
Gasior Kabat M; Bueno D; Sisinni L; De Paz R; Mozo Y; Perona R; Arias-Salgado EG; Rosich B; Marcos A; Romero AB; Constanzo A; Jiménez-Yuste V; Pérez-Martínez A
Int J Hematol; 2021 Jul; 114(1):116-123. PubMed ID: 33772729
[TBL] [Abstract][Full Text] [Related]
60. Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patients.
Teltschik HM; Heinzelmann F; Gruhn B; Feuchtinger T; Schlegel P; Schumm M; Kremens B; Müller I; Ebinger M; Schwarze CP; Ottinger H; Zips D; Handgretinger R; Lang P
Br J Haematol; 2016 Oct; 175(1):115-22. PubMed ID: 27341180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
